NUR 2474 Harvard University Anticoagulation Therapy Presentation

User Generated

onevtbezr

Health Medical

NUR 2474

Harvard University

NUR

Description

Unformatted Attachment Preview

Assignment Scenario After graduating from nursing school and passing your boards, you accepted a position as an RN in the emergency center at Harvard General Hospital (HGH). In the weeks ahead, your emergency center plans to implement a new initiative where clients diagnosed with low-risk deep vein thrombosis (DVT) will be sent home on 3 months of oral anticoagulation therapy with rivaroxaban. Historically, clients diagnosed with DVTs in the emergency center were admitted to the hospital's observation unit. However, when surveyed about their experiences, many clients reported that this was costly, time-consuming, and inconvenient. Under HGH's new program, emergency center nurses will be responsible for educating clients about their new medication and administering the first dose to the client before discharge. As part of this new initiative, all emergency center nurses at HGH must be trained to properly educate these clients on all aspects of their new medication regimen. Because you have demonstrated a keen interest in pharmacology, your manager has asked you to develop the educational tools that will be used to train the nurses at HGH. It's worth noting that the standard dosing for all low-risk DVTs is as follows: 15 mg BID, 12 hours apart, for 21 days After 21 days, use 20 mg once per day After 90 days, the client will follow up in the thrombosis clinic to evaluate if they meet criteria for discontinuing the medication Assignment Instructions Your manager explained that all of the emergency center nurses at HGH will be educated in small groups through a short, in-service training session. You have been asked to develop a professional-looking PowerPoint presentation that the trainers will use to guide the in-service sessions. Your PowerPoint will need to: Be professional-looking, have a title slide, and 10-15 content slides. Use the Speaker Notes feature in PowerPoint to reduce the amount of text that appears on the content slides. The Speaker Notes for each slide will contain the text that will guide what the trainer will say while presenting the slides during the in-service. The content slides themselves should be clear and easy to understand; they serve as an outline so the audience can follow along with what is being presented. Be written using proper spelling/grammar and at a level that would be appropriate for the audience. Remember the purpose of the training is to help nurses learn to educate their clients about the use of a medication. With that in mind, it may be helpful to provide examples of how to explain the information to a client in an easy to understand way without complicated, technical terms. Include APA formatted in-text citations for at least 3 scholarly references and present the sources in APA format on a References slide. Contain content addressing the items below. Pharmacotheraputics State the drug name and its therapeutic category Pharmacodynamics (how does this drug work to achieve its intended response) Pharmacokinetics (how is this drug absorbed, distributed, metabolized, and excreted). Discuss dosage, scheduling, route, and length of therapy. Describe what clients can expect regarding their therapeutic response and when it should develop Introduce nondrug measures that clients can do to enhance their therapeutic response (e.g., specific diet to follow, exercise requirements, substances to avoid, special precautions to take, etc.) Side Effects, Adverse Effects, and Interactions Explain the symptoms of common side effects, and what clients can do to minimize any discomfort Explain the symptoms of any major adverse effects, and what clients should do if they experience them List the major adverse drug-drug interactions and drug-food interactions that clients need to be made aware of Follow-up Care Provide information regarding when clients should call their doctor for advice (e.g., questions, nonurgent symptoms, unpleasant side effects, etc.) Emphasize any symptoms for which clients should seek immediate care (e.g., when to go to the emergency center or call 911) Note: When developing a professional-looking presentation, it's important to be mindful of how you layout your content. The slides should present key points, arranged in a logical manner, without extraneous information contributing to a cluttered look. Using the Speaker Notes feature in PowerPoint is a great way to include relevant details without overloading the slides. For information about creating PowerPoint presentations or adding Speaker Notes, consult the resources below. Mastery: Advanced or exceeds achievement Met length requirement. Outstanding professional appearance and tone. Speaker notes used for every slide. 5.5 Proficiency: Clear/effective achievement Met length requirement. Strong professional appearance and tone. Speaker notes used for every slide. 4.68 Competence: Adequate/basic achievement Met length requirement. Attempted to use professional appearance and tone. Speaker notes occasionally used. 4.29 Emerging: Limited or growing achievement Did not meet length requirement. Slide content lacks a professional appearance and tone. Speaker notes rarely used. 3.03 Spelling and Grammar 5% of total grade Mastery: Advanced or exceeds achievement No spelling or grammar errors. 2.75 Proficiency: Clear/effective achievement No more than three spelling or grammar errors. Does not detract from the readability of the submission. 2.34 Competence: Adequate/basic achievement No more than five spelling or grammar errors, minimally detracts from the readability of the submission. 2.15 Emerging: Limited or growing achievement Six or more spelling or grammar errors. Detracts from the readability of the submission. 1.51 APA Style 5% of total grade Mastery: Advanced or exceeds achievement No APA errors. 2.75 Proficiency: Clear/effective achievement No more than three APA errors reflected throughout. 2.34 Competence: Adequate/basic achievement No more than five APA errors reflected throughout. 2.15 Emerging: Limited or growing achievement Six or more APA errors reflected throughout. 1.51 Content: Pharmacotheraputics 30% of total grade Mastery: Advanced or exceeds achievement Related slides contain appropriate amount of content. Slide content is explicitly clear and easy to understand. Speaker notes contain a comprehensive discussion of pharmacodynamics, pharmacokinetics, dosing, therapeutic expectations, and nondrug measures to enhance response. 16.5 Proficiency: Clear/effective achievement Related slides contain appropriate amount of content; slide content is sufficiently clear and easy to understand. Speaker notes contain a complete discussion of pharmacodynamics, pharmacokinetics, dosing, therapeutic expectations, and nondrug measures to enhance response. 14.03 Competence: Adequate/basic achievement Related slides contain appropriate amount of content; slide content is reasonably clear and easy to understand. Speaker notes contain a moderate discussion of pharmacodynamics, pharmacokinetics, dosing, therapeutic expectations, and nondrug measures to enhance response. 12.87 Emerging: Limited or growing achievement Related slides contain far too much content; slide content is not clear and easy to understand. Speaker notes contain little discussion or inaccurate discussion of pharmacodynamics, pharmacokinetics, dosing, therapeutic expectations, and nondrug measures to enhance response. 9.08 Content: Side Effects, Adverse Effects, and Interactions 30% of total grade Mastery: Advanced or exceeds achievement Related slides contain appropriate amount of content. Slide content is explicitly clear and easy to understand. Speaker notes contain a comprehensive discussion of side effects, adverse effects, and interactions. 16.5 Proficiency: Clear/effective achievement Related slides contain appropriate amount of content; slide content is sufficiently clear and easy to understand. Speaker notes contain a complete discussion of side effects, adverse effects, and interactions. 14.03 Competence: Adequate/basic achievement Related slides contain appropriate amount of content; slide content is reasonably clear and easy to understand. Speaker notes contain a moderate discussion of side effects, adverse effects, and interactions. 12.87 Emerging: Limited or growing achievement Related slides contain far too much content; slide content is not clear and easy to understand. Speaker notes contain little discussion or inaccurate discussion of side effects, adverse effects, and interactions. 9.08 Content: Follow-up Care 20% of total grade Mastery: Advanced or exceeds achievement Related slides contain appropriate amount of content. Slide content is explicitly clear and easy to understand. Speaker notes contain a comprehensive discussion of follow up care. 11 Proficiency: Clear/effective achievement Related slides contain appropriate amount of content; slide content is sufficiently clear and easy to understand. Speaker notes contain a complete discussion of follow-up care. 9.35 Competence: Adequate/basic achievement Related slides contain appropriate amount of content; slide content is reasonably clear and easy to understand. Speaker notes contain a moderate discussion of follow-up care. 8.58 Emerging: Limited or growing achievement Related slides contain far too much content; slide content is not clear and easy to understand. Speaker notes contain little discussion or inaccurate discussion of follow-up care. Anticoagulation Therapy Module 09 Assignment: Medication Presentation Harvard University Presented by Ruth M Gbenete Anticoagulation therapy ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here ▪ Directions: Define the terminology with bullet points. ▪ Expand on your bullet points in the SPEAKERS NOTES; use APA citation. Pharmacotherapeutics: rivaroxaban ▪ State the drug name and its therapeutic and pharmacologic category ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Pharmacodynamics of rivaroxaban ▪ How does this drug work to achieve its intended response? ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Pharmacokinetics ▪ How is this drug absorbed, distributed, metabolized, and excreted? ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Administration ▪ Discuss dosage, scheduling, route, and length of therapy. ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Therapeutic Response ▪ Describe what clients can expect regarding their therapeutic response and when it should develop ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Nondrug Actions/Measures ▪ Introduce nondrug measures that clients can do to enhance their therapeutic response (e.g., specific diet to follow, exercise requirements, substances to avoid, special precautions to take, etc.) ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Side Effects ▪ Explain the symptoms of common side effects, and what clients can do to minimize any discomfort ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Adverse Effects ▪ Explain the symptoms of any major adverse effects, and what clients should do if they experience them ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Therapeutic Response ▪ Describe what clients can expect regarding their therapeutic response and when it should develop ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Interactions ▪ List the major adverse drug-drug; drug-food; drug-lifestyle; drug-herb interactions that clients need to be made aware of ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Follow-up Care: Contact the Provider & Nurse… ▪ Follow-up Care: Provide information regarding when clients should call their doctor for advice (e.g., questions, non-urgent symptoms, unpleasant side effects, etc.) ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Seek Immediate Attention! ▪ Emphasize any symptoms for which clients should seek immediate care (e.g., when to go to the emergency center or call 911) ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here Patient Education Resources This is optional- You can find a few (1-5) websites to share with your audience ▪ Website https://www.xareltohcp.com/nonvalvular-atrialfibrillation/dosing?&utm_source=google&utm_medium=cpc&utm_campaign=GO-USA-ENG-PS-XareltoBC-EX-RNHCP&utm_content=Rivaroxaban&utm_term=rivaroxaban&gclid=Cj0KCQjwna2FBhDPARIsACAEc_XXKq a_JbM2sUoiHUDnGZq83V_1E2EOrPPy2s7MtsCnFH13bURRho4aAm71EALw_wcB&gclsrc=aw.ds ▪ Add your first bullet point here ▪ Add your second bullet point here ▪ Add your third bullet point here References Burchum, J.R. & Rosenthal, L.D. (2019). Lehnes pharmacology for nursing care.(10th ed.). St. Louis, MO: Elsevier. Assessment Technologies Institute. (2019). Pharmacology for nursing : Review module (10th ed.). Assessment Technologies Institute. https://reference.medscape.com/drug/xarelto-rivaroxaban-999670 https://medlineplus.gov/druginfo/meds/a611049.html
Purchase answer to see full attachment
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Explanation & Answer

View attached explanation and answer. Let me know if you have any questions.

Anticoagulation
Therapy
Assignment: Medication Presentation
Institution Affiliation
Presented by (Name)

Anticoagulation therapy
▪ Anticoagulants are medical drugs that prevent normal blood clotting.

▪ Anticoagulation therapy refers to the treatment for slowing down or stopping the
mechanism of blood clotting.
▪ It gives the body time to resolve any blood clot in its early stages.

Pharmacotherapeutics: rivaroxaban
▪ Drug name: Rivaroxaban.
▪ Therapeutic category: anticoagulants.
▪ Pharmacologic category: factor Xa inhibitor.

Pharmacodynamics of rivaroxaban
▪ It targets factor Xa to compromise its operation.
▪ The work of rivaroxaban is to inhibit factor Xa to make clotting as slow as possible
(Bratsos, 2019).
▪ Makes it hard for the body to produce thrombin.

Pharmacokinetics
▪ It gets absorbed into the plasma after oral intake.
▪ The volume at which rivaroxaban gets distributed is about 50L.
▪ 51% of rivaroxaban undergo metabolism and finally excreted through the urine
(30%) and feces (21%) (Singh et al., 2020).

Administration
▪ The recommended dosage of this drug is 15 mg bid for 21 days.
▪ Schedule for rivaroxaban should include taking the medication after every 12
hours (Cohen & Bauersachs, 2019).
▪ The standard duration of anticoagulation therapy is three months (Cohen &
Bauersachs, 2019).

Therapeutic Response
▪ The patient should expect reduced symptoms of DVTs to vanish.
▪ The pain should start to reduce after 2 to 4 hours .
▪ After 21 days, the swelling and discolored skin should go away.

Nondrug Actions/Measures
▪ Avoid fatty food.
▪ Become more active.
▪ Minimize alcohol intake.

Side Effects
▪ Back pain, mild abdominal pain, fatigue, and dizziness.
▪ To reduce back pain and abdominal pain, the patient can take paracetamol.
▪ Do physical exercises to re...


Anonymous
Nice! Really impressed with the quality.

Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4

Similar Content

Related Tags